Skip to main content
logo
CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
0.8611
-0.0189 (-2.15%)
At close: Sep 4, 2026, 4:00 PM EDT
0.8610
-0.0001 (-0.01%)
After-hours: Sep 4, 2026, 6:04 PM EDT

CytoMed Therapeutics Cash Flow Statement

Millions SGD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-3.98-2.52-4.13-3.13-2.05
Depreciation & Amortization
0.40.330.380.390.33
Other Amortization
00--0
Loss (Gain) From Sale of Assets
----0-
Asset Writedown & Restructuring Costs
0.01--0-
Loss (Gain) From Sale of Investments
-0.29----
Loss (Gain) on Equity Investments
0.01-0.010.030.030.21
Stock-Based Compensation
0.69----
Other Operating Activities
-0.05-0.450.081.20.17
Change in Accounts Receivable
-0.56-0.08-0.01-0.15-0.43
Change in Accounts Payable
-0-0.080.110.270.06
Change in Unearned Revenue
0.070.10-0.01-
Operating Cash Flow
-3.7-2.71-3.53-1.4-1.71
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.64-1.4-0.06-0.47-0.58
Sale of Property, Plant & Equipment
---0-
Divestitures
0.70.16---
Sale (Purchase) of Intangibles
-0.07-0.09---
Investment in Securities
0.772.5-2.77--0.24
Other Investing Activities
0.130.470.1--
Investing Cash Flow
0.931.13-2.73-0.47-0.82

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
---0.30.35
Total Debt Issued
---0.30.35
Short-Term Debt Repaid
---0.3-0.35-
Long-Term Debt Repaid
-0.05-0.04-0.04-0.08-0.06
Lease Payments
-0.02-0.01-0.01-0.01-0.01
Total Debt Repaid
-0.05-0.04-0.34-0.43-0.06
Net Debt Issued (Repaid)
-0.05-0.04-0.34-0.130.29
Issuance of Common Stock
0.28-11.311.224
Other Financing Activities
-0.02-0.02-0.05-0.13-0.12
Financing Cash Flow
0.21-0.0610.920.974.17

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.040.12-0.01-0.03-0.01
Net Cash Flow
-2.6-1.534.64-0.931.63

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-4.34-4.11-3.59-1.87-2.3
Free Cash Flow Growth
-----
Free Cash Flow Margin
-503.61%-816.52%-706.96%-514.47%-2016.27%
Free Cash Flow Per Share
-0.37-0.36-0.34-0.24-0.33
Levered Free Cash Flow
-2.72-3.17-2.04-1.29-1.75
Unlevered Free Cash Flow
-2.7-3.16-2.01-1.21-1.68
Free Cash Flow After Leases
-4.35-4.12-3.6-1.88-2.3

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.020.020.050.130.12
Cash Income Tax Paid
--0--
Change in Working Capital
-0.49-0.060.10.11-0.37
SEC Filings: 10-K · 10-Q